West Pharma expanding plant for making wearable injectors; Will cancer become a chronic condition?;

> West Pharmaceutical Services ($WST) is expanding its Scottsdale, AZ, facility to increase production of its SmartDose Electronic Wearable Injector. The device adheres to the patient's abdomen to deliver pre-programmed volumes of drug. More

> Researchers have designed a method of evaluating the performance of various polymer drug-delivery formulations thanks to imaging via luminescent quantum dots. More

> Dr. Julia Ljubimova, the director of the Nanomedicine Research Center at Cedars-Sinai in Los Angeles, envisions using nanotechnology to turn cancer into a chronic condition, akin to diabetes. More

Suggested Articles

The new digital Abilify is a breakthrough for Proteus Digital Health and its patient-tracking products, but not so much for Abilify's maker, Otsuka.

Adamis Pharmaceuticals' EpiPen contender Symjepi, which was rejected last year before the EpiPen havoc, won approval from the FDA.

Researchers in the U.K. have developed a technique to better predict results in liver cancer when drug-laden polymer beads are used to deliver medicines.